BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» 'Deep-Priming' technology adds new 'Torque' to cancer immunotherapy
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
'Deep-Priming' technology adds new 'Torque' to cancer immunotherapy
Nov. 15, 2017
By
Marie Powers
No Comments
Torque Therapeutics Inc. emerged from the deep, disclosing a series A by Flagship Pioneering that was opened in conjunction with its founding in 2015 and, with a second tranche pulled down in August, amounts to $25 million.
BioWorld